menu
    • menu

    Company profile for Pacira BioSciences

    NEW Drugs in Dev: 9
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pacira BioSciences, Inc. (Nasdaq: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and prop...
    Pacira BioSciences, Inc. (Nasdaq: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pacira BioSciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Sylvan Way Parsippany, NJ 07054
    Telephone
    Telephone
    (973) 254 3560
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pacira.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pacira-biosciences-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pacira BioSciences Issues Inducement Grants Under Nasdaq Rule
    Pacira BioSciences Issues Inducement Grants Under Nasdaq Rule

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291026/0/en/pacira-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Pacira Biosciences Mails Letter To Stockholders
    Pacira Biosciences Mails Letter To Stockholders

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3288297/0/en/pacira-biosciences-mails-letter-to-stockholders.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share
    Pacira Biosciences Reports First Quarter 2026 Financial Results
    Pacira Biosciences Reports First Quarter 2026 Financial Results

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7257113

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    Pacira Files Proxy Materials, Sends Letter to Shareholders
    Pacira Files Proxy Materials, Sends Letter to Shareholders

    28 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7234223

    FIRSTWORD PHARMA
    28 Apr 2026
    Share Share
    EXPAREL Cuts Opioid Use, Costs in Hip Surgery Medicare Data
    EXPAREL Cuts Opioid Use, Costs in Hip Surgery Medicare Data

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281543/0/en/real-world-data-on-exparel-shows-reduced-opioid-use-and-lower-total-medical-costs-in-medicare-patients-undergoing-total-hip-arthroplasty.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Pacira To Release Q1 2026 Financial Results On April 30
    Pacira To Release Q1 2026 Financial Results On April 30

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275304/0/en/Pacira-to-Report-First-Quarter-2026-Financial-Results-on-Thursday-April-30-2026.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search